This announcement is a separate document:
君實生物：海外監管公告 - 上海君實生物醫藥科技股份有限公司自願披露關於特瑞普利單抗用於腎細胞癌一線治療的新適應症上市申請獲得批准的公告
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.